Many drugs being used to treat Malaria in disease ridden areas could be substitutes, or could even be fake.
The Lancet Infectious Disease Journal reported that up to 42% of the Malaria drugs used in Southeast Asia or Sub-Saharan Africa could be ineffective, being either counterfeit medication, a substitute medication or just a placebo.
The governments of the countries where these ineffective drugs were discovered are being urged to regulate drug production more strictly.
People along the borders of Thailand and Myanmar have been found to carry a Malarial parasite that is immune to the best anti-Malarial drugs available, called artemisinin combination therapy, or ACT. In Cambodia, drug resistant Malarial parasites were also discovered. These new cases showing up along the borders of Thailand and Myanmar are different in the fact that it is a different parasite these patients are carrying.
“Anti-malarial control efforts are vitally dependent on artemisinin combination treatments,” says Anne-Catrin Uhlemann and David Fidock of Columbia University. “Should these regimens fail, no other drugs are ready for deployment, and drug development efforts are not expected to yield new antimalarials until the end of this decade.”